Time Well Spent: Treating Obesity and Diabetes

Estimated Time
2.00 hr

Release Date
Nov 10, 2023

Expiration Date
Nov 09, 2024

Community Collective: Time Well Spent – Navigating the Challenges of Treating Obesity and Diabetes is an educational curriculum designed for rural primary care clinicians to enhance outcomes for individuals with obesity through improved diagnosis and use of therapy options to treat type 2 diabetes (T2D). This regional series consists of three individual activities (2 virtual and 1 live in-person) tailored to the educational needs of rural U.S.-based clinicians who treat patients with T2D and obesity and practice in geographic areas with a greater prevalence of the disease. Local experts will share their experiences in the treatment of T2D and obesity and will also discuss disease-related risk factors and comorbidities, strategies to treating and managing T2D and obesity, the most recent safety and efficacy data for approved and emerging T2D medications, as well as approaches for shared decision-making and addressing health inequities within rural populations. Community Collective is designed to facilitate networking and collaborative consultation among local clinicians and practicing clinicians who practice in your area.


Accreditation and Disclosure Information

Target Audience
This activity is intended for physicians, physician associates, nurse practitioners, and nurses, involved in the care of patients with both T2D and obesity.

Educational Objectives
After completing this activity, the participant should be better able to:

  • Use three evidence-based screening metrics beyond HbA1C (OGTT, GV, TIR) to assess whether to initiate or intensify T2D therapy, with consideration of obesity as a comorbidity.
  • Determine the chronicity of obesity as a comorbidity and the importance of its timely management to mitigate risk of longterm complications in T2D.
  • Select the most appropriate therapy for an individual patient with T2D and obesity with consideration of the latest safety and efficacy data of GLP-1 RAs and dual GIP/GLP-1 RAs and ADA/EASD Consensus Statements.
  • Identify patient- and disease- appropriate goals for the long-term management of weight loss and T2D related complications utilizing shared decision-making approaches and patient-reported outcomes.

Program Agenda
Part 1, Reframing How We Approach T2D Management in Primary Care: Making Time to Address Obesity in Your Busy Practice

  • Redefining treatment goals and targets in T2D Management
  • Considering the dual management of T2D and obesity: a holistic approach
  • Building a solid foundation for patient collaborating in newly diagnosed T2D

Part 2, Expanding the Role of GLP-1 Receptor Agonists and GIP/GLP-1 Dual Agonists in the Management of T2D and Obesity: Practical Applications for PCPs

  • Latest safety and efficacy data for GLP-1 RAs and dual GIP/GLP-1 RAs in T2D and obesity
  • Establishing trust with shared-decision making: approaches to T2D therapy intensification
  • Putting it to practice: practical approaches in primary care

Accreditation, Support and Credit

In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).

Physician Associate Credit Designation Statement
Medical Learning Institute, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. Approval is valid until November 9, 2024. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 2.0 contact hours and 1.0 contact hour in the area of pharmacology.

Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.


Support Statement
This activity is supported by an educational grant from Lilly.

Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc., is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.

Faculty Disclosures
Robert F. Kushner, MD

Professor, Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Chicago, IL

Robert F. Kushner, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Altimmune, Boehringer Ingelheim, Lilly, Novo Nordisk, Pfizer, Weight Watchers
Research Grant: Novo Nordisk

Carlos Campos, MD, MPH, CDCES
Clinical Adjunct Professor
Department of Family Medicine
UT Health San Antonio
New Braunfels, TX

Carlos Campos, MD, MPH, CDCES, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Boehringer Ingelheim, Lilly, Novo Nordisk
Speakers’ Bureau: Boehringer Ingelheim, Lilly, Novo Nordisk

Keisha Harvey-Mansfield, MD
Diplomate ABFM, Diplomate ABOM, Diplomate ACLM
Medical Director and Founder, Dr. K's Family Medicine
Bogalusa, LA

Keisha Harvey-Mansfield, MD, has no relevant financial relationships with ineligible companies to disclose for this educational activity.

Eden Miller, DO, Dip ABOM

Co-Founder, Diabetes and Obesity Care LLC
Bend, OR

Eden Miller, DO, Dip ABOM, has a financial interest/relationship or affiliation in the form of:
Advisory Board/Consultant: Abbott, Bayer, Eli Lilly/Boehringer Ingelheim, Insulet, Novo Nordisk
Research Grant: Abbott
Speakers’ Bureau: Abbott, Bayer, Eli Lilly/Boehringer Ingelheim, Novo Nordisk

Kevin Miller, DO

Physician, Diabetes and Obesity Care LLC
Bend, OR

Kevin Miller, DO, has a financial interest/relationship or affiliation in the form of:
Research Grant: Abbott
Independent Contractor: Semler Insulin Insights
The following relationships have ended within the last 24 months:
Independent Contractor: Novo Nordisk

All of the relevant financial relationships of individuals for this activity have been mitigated.

Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies unless listed below.

Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. You will receive your certificate from Medical Learning Institute, Inc. If you have questions regarding your certificate, please contact mvu@mlieducation.org.

For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.

For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.

About This Activity
Medical Learning Institute, Inc. is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by an educational grant subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.

Copyright © 2023 Medical Learning Institute, Inc. All Rights Reserved.